Abiopharma

🔍 Lungren Matthew (Executive)

Company: Lumexa Imaging Holdings, Inc. (LMRI)

Report Date: 2026-06-10

Detailed Transactions and Holdings:

• Acquired 19,358 shares of Common Stock (Direct)
  Date: 2026-06-10 | Code: A | equity_swap_involved: false | shares_owned_after: 19,358.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer.
• REMARKS: Exhibit List: Exhibit 24 - Power of Attorney